Trial Profile
Effect of Normalization of Fasting Glucose by Intensified Insulin Therapy on the Incidence of Restenosis After Peripheral Angioplasty in Patients With Type 2 Diabetes.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Biguanides; Insulin; Meglitinide; Sulfonylureas
- Indications Chronic limb-threatening ischemia; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIMBISCH
- 01 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Jun 2010 New trial record